Itani Satoko, Torii Motomi, Ishino Tomoko
Department of Molecular Parasitology, Graduate School of Medicine, Ehime University, Shitsukawa, Toon, Ehime 791-0295, Japan.
Department of Molecular Parasitology, Graduate School of Medicine, Ehime University, Shitsukawa, Toon, Ehime 791-0295, Japan; Division of Molecular Parasitology, Proteo-Science Center, Ehime University, Shitsukawa, Toon, Ehime 791-0295, Japan.
Parasitol Int. 2014 Aug;63(4):584-90. doi: 10.1016/j.parint.2014.03.004. Epub 2014 Mar 30.
The course of malaria infection in mammals begins with transmission of Plasmodium sporozoites into the skin by Anopheles mosquitoes, followed by migration of the sporozoites to the liver. As no symptoms present until hepatic merozoites are released and until they infect erythrocytes in the blood vessels, sporozoites and liver-stage (LS) parasites are promising targets for anti-malaria drugs aiming to prevent mosquito-to-mammal transmission. In vitro LS parasite development system is useful in the screening of candidate drugs on LS parasite development and the elucidation of its underlying molecular mechanisms, which remain unclear. Using rodent malaria parasites (Plasmodium berghei) as a model, this study aimed to develop an optimal in vitro LS culture system for the full maturation of the LS parasite into the hepatic merozoite, the next infective stage in parasite development. As the development of this system required measurement of maturation, a novel quantitative index of LS parasite maturation based on the expression pattern of liver-specific protein 2 (LISP2) was first developed. The use of this index for comparing the effect of incubation in different culture media on LS maturation revealed that the d-glucose concentration of the culture medium is the key factor promoting parasite development in hepatocytes and that a d-glucose concentration of 2000mg/L/day is the threshold concentration at which the maturation of P. berghei into infective hepatic merozoites is achieved. These findings can be utilized to optimize a human malaria LS culture system for drug discovery.
哺乳动物疟疾感染的过程始于按蚊将疟原虫子孢子传播至皮肤,随后子孢子迁移至肝脏。由于在肝内裂殖子释放并感染血管内的红细胞之前没有症状出现,因此子孢子和肝期(LS)寄生虫是旨在预防蚊媒向哺乳动物传播的抗疟药物的理想靶点。体外LS寄生虫发育系统有助于筛选影响LS寄生虫发育的候选药物,并阐明其潜在的分子机制,而这些机制仍不清楚。本研究以啮齿动物疟原虫(伯氏疟原虫)为模型,旨在开发一种最佳的体外LS培养系统,使LS寄生虫完全成熟为肝内裂殖子,即寄生虫发育的下一个感染阶段。由于该系统的开发需要测量成熟度,因此首先基于肝脏特异性蛋白2(LISP2)的表达模式开发了一种新的LS寄生虫成熟定量指标。使用该指标比较不同培养基孵育对LS成熟的影响,结果表明培养基中的d-葡萄糖浓度是促进寄生虫在肝细胞中发育的关键因素,2000mg/L/天的d-葡萄糖浓度是伯氏疟原虫成熟为感染性肝内裂殖子的阈值浓度。这些发现可用于优化用于药物发现的人类疟疾LS培养系统。